Impact of a Multidimensional Intervention in Elderly Patients With Pneumonia (IMIEPAP)
Recruitment status was Recruiting
The hypothesis of this study is that long-term outcome in elderly patients admitted with the diagnosis of community-acquired pneumonia (CAP) or healthcare-associated pneumonia (HCAP) would improve with a multidimensional intervention including assessment of co-morbidities, nutritional, functional and cognitive status and immunization.
Community Acquired Pneumonia
Other: Multidimensional intervention
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
|Official Title:||Impact of a Multidimensional Intervention in Elderly Patients With Pneumonia: a Prospective Randomized Controlled Trial.|
- Healthcare resources utilization (readmissions and consultations to hospital and emergency department). [ Time Frame: 1 year after hospital admission for pneumonia ] [ Designated as safety issue: No ]To achieve the variables related to the healthcare resource utilization, computarized medical records will be reviewed and all patients will be followed up by telephone interview one year after discharge.The cause for readmission will be recorded.
- Functional status [ Time Frame: 1 year after hospital admission for pneumonia ] [ Designated as safety issue: No ]
Data will be obtained by review of medical records and telephone interview one year after discharge.
Dependency in basic activities of daily living will be scored using the Barthel Index (Mahoney & Barthel. Maryland State Med J 14; 61-65) which measures the capacity to perform ten basic activities and gives a quantitative estimation of the patient level of dependency, scoring to 0 (totally dependent) to 100 (totally independent).
- Institutionalization [ Time Frame: 1 year after hospital admission for pneumonia ] [ Designated as safety issue: No ]Data will be obtained by review of medical records and telephone interview one year after discharge.
- Survival [ Time Frame: 1 year after hospital admission for pneumonia ] [ Designated as safety issue: No ]Data will be obtained by review of medical records and telephone interview to patient or relatives one year after discharge.
|Study Start Date:||November 2010|
|Estimated Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|
Experimental: Multidisciplinar intervention
Patients that will receive the multidimensional intervention during the ambulatory follow-up.
Other: Multidimensional intervention
The patient will be cited 2 months after hospital discharge for a geriatric evaluation carried out by a geriatric nurse and an internist with geriatric training. The duration of the first visit is 45-60 minutes. The visit consists of: 1. Assessment of the pneumonia resolution, co-morbidities, aspiration risk, risk of multiresistant infections, and the immunization, functional and cognitive status. 2. An individualized intervention plan. The patient and family or caregiver will receive an educational intervention, a written report with the planned intervention and an educational leaflet. Those patients who require further assessment or follow up of the intervention will receive 1 or 2 more visits and all the patients will be cited one year after the first visit.
Other Name: Comprehensive geriatric assesment
No Intervention: Conventional follow up
This is an observation only group and outpatient follow up will be indicated in accordance with usual and customary practices.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01285869
|Contact: Olga H Torres, Phd||932919000 ext email@example.com|
|Contact: Domingo Ruiz, MD||932919000 ext firstname.lastname@example.org|
|Hospital de la Santa Creu i Sant Pau||Recruiting|
|Barcelona, Spain, 08025|
|Principal Investigator: Olga H Torres, Phd|
|Principal Investigator:||Olga H Torres, Phd||Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|
|Study Chair:||Domingo Ruiz, MD||Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|